Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
Boston Omaha Corporation (BOC): A Bull Case Theory
We came across a bullish thesis on Boston Omaha Corporation (NYSE:BOC) on Substack by LittleBarnSparrow. In this article, we ...